Page 3 - Statements Regarding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Achieves first quarter revenue growth of 8% reported and organic, driven by CAG Diagnostics recurring revenue growth of 8% reported and 9% organic, building on...

/PRNewswire/ -- Achieves 11% fourth quarter revenue growth as reported and 10.5% organic, driven by 13% CAG Diagnostics recurring revenue growth (reported and...

/PRNewswire/ -- Achieves third quarter revenue growth of 12% as reported and 10% on an organic basis compared to high prior year growth levels Results driven...

IDEXX Laboratories Announces First Quarter Results News provided by Share this article WESTBROOK, Maine, May 4, 2021 /PRNewswire/ -- Achieves reported revenue growth of 24% and organic growth of 21%, driven by CAG Diagnostics recurring revenue growth of 27% as reported and 23% organic Delivers EPS of $2.35, representing 82% growth as reported and 73% on a comparable basis Increases 2021 revenue guidance to $3,105 million - $3,160 million, reflecting higher expectations for reported growth of 14.5% - 16.5% and organic growth of 13% - 15%, supported by projected CAG Diagnostics recurring reve...

IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results News provided by Share this article WESTBROOK, Maine, Feb. 2, 2021 /PRNewswire/ --  Achieves fourth quarter reported revenue growth of 19% and organic growth of 17%, driven by CAG Diagnostics recurring revenue reported growth of 23% and organic growth of 21% High revenue growth supported by sustained strong global trends in pet healthcare Delivers full year EPS of $6.71, an increase of 37% on a reported basis and 31% on a comparable constant currency basis Strong full year EPS results supported by operating margin expans...